Tower Research Capital (TRC)’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,533
| Closed | -$84K | – | 6721 |
|
|
2022
Q4 | $84K | Sell |
2,533
-824
| -25% | -$26.5K | ﹤0.01% | 1973 |
|
|
2022
Q3 | $106K | Buy |
3,357
+1,995
| +146% | +$64.6K | ﹤0.01% | 2523 |
|
|
2022
Q2 | $41K | Sell |
1,362
-3,970
| -74% | -$107K | ﹤0.01% | 3092 |
|
|
2022
Q1 | $138K | Buy |
5,332
+5,120
| +2,415% | +$122K | ﹤0.01% | 1998 |
|
|
2021
Q4 | $4K | Sell |
212
-583
| -73% | -$11.2K | ﹤0.01% | 5386 |
|
|
2021
Q3 | $15K | Sell |
795
-1,139
| -59% | -$22.7K | ﹤0.01% | 4012 |
|
|
2021
Q2 | $43K | Sell |
1,934
-5,468
| -74% | -$116K | ﹤0.01% | 3158 |
|
|
2021
Q1 | $195K | Buy |
7,402
+4,052
| +121% | +$96.3K | ﹤0.01% | 2035 |
|
|
2020
Q4 | $62K | Sell |
3,350
-34,459
| -91% | -$643K | ﹤0.01% | 2887 |
|
|
2020
Q3 | $642K | Buy |
37,809
+32,183
| +572% | +$625K | 0.01% | 1405 |
|
|
2020
Q2 | $131K | Buy |
+5,626
| New | +$81.5K | 0.01% | 2212 |
|
|
2019
Q4 | – | Sell |
-1,152
| Closed | -$11K | – | 4644 |
|
|
2019
Q3 | $11K | Buy |
+1,152
| New | +$12.1K | ﹤0.01% | 2900 |
|
|
2019
Q2 | – | Sell |
-242
| Closed | -$4K | – | 4517 |
|
|
2019
Q1 | $4K | Buy |
+242
| New | +$4.03K | ﹤0.01% | 3229 |
|
|
2018
Q1 | – | Sell |
-3,091
| Closed | -$44K | – | 4027 |
|
|
2017
Q4 | $44K | Sell |
3,091
-1,234
| -29% | -$18.1K | 0.01% | 1432 |
|
|
2017
Q3 | $61K | Buy |
4,325
+4,125
| +2,063% | +$58.9K | 0.01% | 1796 |
|
|
2017
Q2 | $3K | Buy |
+200
| New | +$2.88K | ﹤0.01% | 2262 |
|
|
2017
Q1 | – | Sell |
-174
| Closed | -$3K | – | 4155 |
|
|
2016
Q4 | $3K | Buy |
+174
| New | +$3.06K | ﹤0.01% | 3315 |
|
|
2016
Q3 | – | Sell |
-6,006
| Closed | -$117K | – | 4709 |
|
|
2016
Q2 | $117K | Buy |
6,006
+5,607
| +1,405% | +$110K | 0.01% | 1005 |
|
|
2016
Q1 | $8K | Buy |
399
+10
| +3% | +$197 | ﹤0.01% | 2264 |
|
|
2015
Q4 | $8K | Sell |
389
-5,058
| -93% | -$97K | ﹤0.01% | 2473 |
|
|
2015
Q3 | $93K | Buy |
5,447
+823
| +18% | +$15K | 0.01% | 609 |
|
|
2015
Q2 | $86K | Buy |
4,624
+1,257
| +37% | +$23.3K | 0.01% | 965 |
|
|
2015
Q1 | $64K | Buy |
3,367
+2,446
| +266% | +$45.2K | 0.01% | 1269 |
|
|
2014
Q4 | $15K | Sell |
921
-1,602
| -63% | -$27.5K | ﹤0.01% | 1814 |
|
|
2014
Q3 | $45K | Buy |
+2,523
| New | +$49.6K | 0.01% | 1625 |
|
|
2014
Q2 | – | Sell |
-61
| Closed | -$1K | – | 4792 |
|
|
2014
Q1 | $1K | Buy |
+61
| New | +$1.4K | ﹤0.01% | 4241 |
|
|
2013
Q4 | – | Sell |
-2,480
| Closed | -$58K | – | 5030 |
|
|
2013
Q3 | $58K | Buy |
2,480
+2,180
| +727% | +$50.9K | 0.01% | 1783 |
|
|
2013
Q2 | $6K | Buy |
+300
| New | +$6.47K | ﹤0.01% | 2843 |
|
Other funds holding VIVO
Tower Research Capital (TRC)'s VIVO Position: Q1 2023 in Review
Tower Research Capital (TRC) sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 2,533 shares — an estimated $84K sold.
Tower Research Capital (TRC) first reported a position in VIVO in Q2 2013 and held it in 28 quarters. The position peaked at $642K in Q3 2020. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Tower Research Capital (TRC) reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 2,533 Meridian Bioscience Inc shares in Q1 2023, an estimated $84K.
- Tower Research Capital (TRC) first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 28 quarters.
- Tower Research Capital (TRC)'s Meridian Bioscience Inc position peaked at $642K in Q3 2020.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.